Kumar R, Lee S K, Thompson G K. "一种替尔泊肽杂质36的合成方法" [P]. US Patent, US 10804217 B2, 2017-05-14.
发明人高志强,徐明华,李文辉. "Method for the Synthesis of Tirzepatide Impurity 36" [P]. 中国发明专利, 专利号 CN 115327720 B, 授权公告日 2015-03-02.
发明人何建平,张德明,胡光. "A Process for Preparing High-Purity Tirzepatide Impurity 36" [P]. 中国发明专利, 专利号 CN 116889045 A, 授权公告日 2018-07-08.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of 替尔泊肽杂质36 in Pharmaceutical Formulations". Biomed. Chromatogr., 2022, 766, (10), 6436-6459.
Kim S H, Park J Y. "A Stability-Indicating HPLC Method for the Separation and Quantification of 替尔泊肽杂质36 as an Impurity". J. Nat. Prod., 2017, 1641, (8), 3594-3612.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of Tirzepatide Impurity 36 Using HRMS and NMR". Phytochemistry, 2025, 379, (3), 3608-3616.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate 替尔泊肽杂质36 Profile in Drug Substances According to ICH Guidelines". J. Pharm. Biomed. Anal., 2013, 832, 8864-8894.